Comparative Study of Immunomodulatory Properties of Muramyl Peptides On Immune System Cells of Yg and Old Mice

References

• Doria G., Adorini L., Frasca D. Aging and the Immune response, E. A. Goidl. Marcel Dekker, New York and Basel 1987; 143
   Google Scholar
• Zharhary, Klinman D. N.R. Aging and the Immune response, E. A. Goidl. Marcel Dekker, New York and Basel 1987; 81
   Google Scholar
• Miller R. A. Handbook of the Biology of Aging, E. L. Schneider, J. W. Rowe. Academic Press, New York 1990; 157
   Google Scholar
• Miller R. A. Aging and immune function. Internal. Rev. Cytology 1991; 124: 187
   PubMedGoogle Scholar
• Miller R. A. Age-associated decline in precursor frequencies for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell. J. Immunol. 1984; 132: 63
   PubMedGoogle Scholar
• Miller R. A. Aging and the Immune response, E. A. Goidl. Marcel Dekker, New York and Basel 1987; 1
   Google Scholar
• Dozmorov I. M., Bagaeva L. V., Kuzin I. I., Svirshchevskaya E. V. Target cells for immunomodulatory action of muramyl dipeptide. Biomed. Sci. 1991; 2: 193
   PubMedGoogle Scholar
• Dozmorov I. M., Bagaeva L. V., Kuzin I. I., Sapozhnikov A. M., Svirshchevskaya E. V., Andronova T. M., Petrov R. V. Muramyl dipeptide -induced changes in murine splenocyte responses to concanavalin A. Int. J. Immunopharmac. 1992; 14: 159
   PubMed Web of Science ®Google Scholar
• Dziarski R. Enhancement of B-cell stimulation by muramyl dipeptide through a mechanism not involving interleukin 1 or increased Ca2+ mobilization of protein kinase C activation. Cell. Immunol. 1988; 111: 10
   PubMedGoogle Scholar
• Souvannavong V., Brown S., Adam A. The synthetic immunomodulator muramyl dipeptide (MDP) can stimulate activated B cells. Molecular Immunol. 1988; 25: 385
   PubMedGoogle Scholar
• Rostovtseva L. I., Andronova T. M., Mal'kova V. P., Sorokina I. B., Ivanov V. T. Synthesis and anti-tumour activity of glycopeptides containing an N-acetylglucosaminyl-bl-4-N- acetylmuramyl-dlsaccharide unit. Bioorganicheskaya Khimia 1981; 7: 1843, in Russian
   Google Scholar
• Nesmeyanov V. A., Khaidukov S. V., Komaleva R. L., Andronova T. M., Ivanov V. T. Muramylpeptides augment expression of Ia-antigens on mouse macrophages. Biomed. Sci. 1990; 1: 151
   PubMedGoogle Scholar
• Merser P., Sinay P., Adam A. Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 1975; 66: 1316
   PubMed Web of Science ®Google Scholar
• Mishell R. I., Dutton R. W. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 1967; 126: 423
   PubMed Web of Science ®Google Scholar
• Jerne N. K., Nordin A. A. Plaque formation in agar by single antibody-producing cells. Science 1963; 140: 405
   Web of Science ®Google Scholar
• Harwell L., Kappler J. W., Marrack P. Antigen-specific and nonspecific mediators of T cell / B cell cooperation. III. Characterization of Nonspecific Mediator(s) from Different Sources. J. Immunol. 1976; 116: 1379
   PubMedGoogle Scholar
• Corley R. B., Kindred B., Lefkovits I. Positive and negative allogeneic effects mediated by MLR-primed lymphocytes: quantization by limiting dilution analysis. J. Immunol. 1978; 121: 1082
   PubMedGoogle Scholar
• Lefkovits I. Immunological methods, I. Lefkovits, B. Pernis. Academic Press, New York 1979; 364
   Google Scholar
• Miller R. A., Stutman O. Enumeration of IL-2-secreting Th by LDA and demonstration of unexpectedly high levels of IL-2 production per responding cell. J. Immunol. 1982; 128: 2258
   PubMedGoogle Scholar
• Rocha B. Population kinetics of precursors of IL-2-producing peripheral T lymphocytes: evidence for short life expectancy, continuous renewal, and post-thymic expansion. J. Immunol. 1987; 139: 365
   PubMedGoogle Scholar
• Fazekas de St. Groth B. The evaluation of limiting dilution methods. J. Immunol. Meth. 1982; 49: R11
   Web of Science ®Google Scholar
• Conlon P. J. A rapid biologic assay for the detection of interleukin 1. J. Immunol. 1982; 131: 1280
   Google Scholar
• Thoman M. L., Weigle W. O. Aging and the Immune response, E. A. Goidl. Marcel Dekker, New York and Basel 1987; 199
   Google Scholar
• Leclerc C., Juy D., Chedid L. Inhibitory and stimulating effects of a synthetic glycopeptide (MDP) on the in vivo PFC response: factors affecting the response. Cell. Immunol. 1979; 42: 336
   PubMed Web of Science ®Google Scholar
• Kishimoto T., Hirai Y, Nakanishi K, Azuma I, Nagamatsu A, Yamamura Y. Regulation of antibody response in different immunoglobulin classes. J. Immunol. 1979; 123: 2709
   PubMedGoogle Scholar
• Souvannavong V., Adam A. Restoration and stimulation of the in vivo immune response of B cells to sheep erythrocytes by interleukins and muramyl dipeptide. Biochem. Biophys. Res. Commun. 1984; 125: 431
   PubMedGoogle Scholar
• Souvannavong V., Rimsky L., Adam A. In vitro immune response to sheep erythrocytes in macrophage depleted cultures. Restoration with interleukine 1 or a monokine from resident macrophages and stimulation by MDP, Biochem. Biophy. Res. Commun. 1983; 114: 721
   PubMedGoogle Scholar
• Souvannavong V., Adam A. Opposite effects of the synthetic adjuvant MDP on the immune response in mice depending on experimental conditions. Eur. J. Immunol 1980; 10: 654
   PubMedGoogle Scholar
• Al'perina E. L., Zidek Z., Idova G. V., Devoino L. V. Involvement of dophaminergic system in muramylpeptide - induced stimulation of immune response. Bulletin of Experimental Biology and Medicine 1988; 106: 198, in Russian
   Google Scholar
• Adam A., Lederer E. Muramyl peptides: immunomodulators, sleep factors and vitamins. Med. result. Rev. 1984; 4: 111
   PubMed Web of Science ®Google Scholar